Cargando…
Identification of impurities in nafamostat mesylate using HPLC-IT-TOF/MS: A series of double-charged ions
Nafamostat mesylate is a serine protease inhibitor used in the treatment of acute pancreatitis. The impurities in nafamostat mesylate, the active pharmaceutical ingredient (API), were profiled via high performance liquid chromatography tandem ion trap coupled with time-of-flight mass spectrometer (H...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Xi'an Jiaotong University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474109/ https://www.ncbi.nlm.nih.gov/pubmed/32923008 http://dx.doi.org/10.1016/j.jpha.2020.03.002 |
_version_ | 1783579284521091072 |
---|---|
author | Zhang, Yuxin An, Lufan Zhang, Lin Wang, Rulin Tian, Yuan Zhang, Zunjian |
author_facet | Zhang, Yuxin An, Lufan Zhang, Lin Wang, Rulin Tian, Yuan Zhang, Zunjian |
author_sort | Zhang, Yuxin |
collection | PubMed |
description | Nafamostat mesylate is a serine protease inhibitor used in the treatment of acute pancreatitis. The impurities in nafamostat mesylate, the active pharmaceutical ingredient (API), were profiled via high performance liquid chromatography tandem ion trap coupled with time-of-flight mass spectrometer (HPLC-IT-TOF/MS). The chromatography was performed on an ACE-3 C(18) column (200 mm × 4.6 mm, 3 μm) using methanol and 0.1% formic acid in purified water as mobile phase at a flow rate of 1.0 mL/min. The ions were detected by IT-TOF/MS with a full-scan mass analysis from m/z 100 to 800. In total, eleven impurities were detected in nafamostat mesylate API. The impurity profile was estimated based on the HPLC-IT-TOF/MS data, including accurate masses, MS(n) fingerprints of fragmentation pathways and a series of double-charged ions. Finally, seven impurities were identified and reported for the first time. The results will provide technical support for the quality control and clinical safety of nafamostat mesylate. |
format | Online Article Text |
id | pubmed-7474109 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Xi'an Jiaotong University |
record_format | MEDLINE/PubMed |
spelling | pubmed-74741092020-09-11 Identification of impurities in nafamostat mesylate using HPLC-IT-TOF/MS: A series of double-charged ions Zhang, Yuxin An, Lufan Zhang, Lin Wang, Rulin Tian, Yuan Zhang, Zunjian J Pharm Anal Original Article Nafamostat mesylate is a serine protease inhibitor used in the treatment of acute pancreatitis. The impurities in nafamostat mesylate, the active pharmaceutical ingredient (API), were profiled via high performance liquid chromatography tandem ion trap coupled with time-of-flight mass spectrometer (HPLC-IT-TOF/MS). The chromatography was performed on an ACE-3 C(18) column (200 mm × 4.6 mm, 3 μm) using methanol and 0.1% formic acid in purified water as mobile phase at a flow rate of 1.0 mL/min. The ions were detected by IT-TOF/MS with a full-scan mass analysis from m/z 100 to 800. In total, eleven impurities were detected in nafamostat mesylate API. The impurity profile was estimated based on the HPLC-IT-TOF/MS data, including accurate masses, MS(n) fingerprints of fragmentation pathways and a series of double-charged ions. Finally, seven impurities were identified and reported for the first time. The results will provide technical support for the quality control and clinical safety of nafamostat mesylate. Xi'an Jiaotong University 2020-08 2020-03-03 /pmc/articles/PMC7474109/ /pubmed/32923008 http://dx.doi.org/10.1016/j.jpha.2020.03.002 Text en © 2020 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Zhang, Yuxin An, Lufan Zhang, Lin Wang, Rulin Tian, Yuan Zhang, Zunjian Identification of impurities in nafamostat mesylate using HPLC-IT-TOF/MS: A series of double-charged ions |
title | Identification of impurities in nafamostat mesylate using HPLC-IT-TOF/MS: A series of double-charged ions |
title_full | Identification of impurities in nafamostat mesylate using HPLC-IT-TOF/MS: A series of double-charged ions |
title_fullStr | Identification of impurities in nafamostat mesylate using HPLC-IT-TOF/MS: A series of double-charged ions |
title_full_unstemmed | Identification of impurities in nafamostat mesylate using HPLC-IT-TOF/MS: A series of double-charged ions |
title_short | Identification of impurities in nafamostat mesylate using HPLC-IT-TOF/MS: A series of double-charged ions |
title_sort | identification of impurities in nafamostat mesylate using hplc-it-tof/ms: a series of double-charged ions |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474109/ https://www.ncbi.nlm.nih.gov/pubmed/32923008 http://dx.doi.org/10.1016/j.jpha.2020.03.002 |
work_keys_str_mv | AT zhangyuxin identificationofimpuritiesinnafamostatmesylateusinghplcittofmsaseriesofdoublechargedions AT anlufan identificationofimpuritiesinnafamostatmesylateusinghplcittofmsaseriesofdoublechargedions AT zhanglin identificationofimpuritiesinnafamostatmesylateusinghplcittofmsaseriesofdoublechargedions AT wangrulin identificationofimpuritiesinnafamostatmesylateusinghplcittofmsaseriesofdoublechargedions AT tianyuan identificationofimpuritiesinnafamostatmesylateusinghplcittofmsaseriesofdoublechargedions AT zhangzunjian identificationofimpuritiesinnafamostatmesylateusinghplcittofmsaseriesofdoublechargedions |